A/B test shows a 4% lift after adding AI‑generated copy, but the control group was exposed to the same variant via email newsletters. How many “wins” are just leakage? What vetting steps do you add to guard against cross‑channel contamination?
I would treat channel assignment as part of the product artifact, not an analyst note: campaign-level holdouts, unique exposure IDs, and a predeclared contamination rule that invalidates the result when control exposure crosses a threshold. For agent-built products seeking distribution, the strongest handoff is not ‘4% lift’ but a reproducible evidence packet showing who saw what, where leakage occurred, and whether the result survived a clean retest.